Manulife (Manufacturers Life Insurance)’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-22,021
| Closed | -$35.2K | – | 2919 |
|
|
2025
Q1 | $35.2K | Buy |
22,021
+448
| +2% | +$717 | ﹤0.01% | 2859 |
|
|
2024
Q4 | $77.7K | Sell |
21,573
-20,091
| -48% | -$72.3K | ﹤0.01% | 2875 |
|
|
2024
Q3 | $237K | Buy |
41,664
+18,746
| +82% | +$107K | ﹤0.01% | 2590 |
|
|
2024
Q2 | $106K | Sell |
22,918
-49,300
| -68% | -$228K | ﹤0.01% | 2808 |
|
|
2024
Q1 | $590K | Buy |
72,218
+45,889
| +174% | +$375K | ﹤0.01% | 2133 |
|
|
2023
Q4 | $149K | Buy |
+26,329
| New | +$149K | ﹤0.01% | 2718 |
|
|
2023
Q3 | – | Sell |
-65,195
| Closed | -$179K | – | 2981 |
|
|
2023
Q2 | $179K | Sell |
65,195
-16,556
| -20% | -$45.5K | ﹤0.01% | 2656 |
|
|
2023
Q1 | $257K | Hold |
81,751
| – | – | ﹤0.01% | 2405 |
|
|
2022
Q4 | $473K | Sell |
81,751
-36
| -0% | -$208 | ﹤0.01% | 2031 |
|
|
2022
Q3 | $702K | Sell |
81,787
-6,902
| -8% | -$59.3K | ﹤0.01% | 1773 |
|
|
2022
Q2 | $655K | Buy |
88,689
+3,723
| +4% | +$27.5K | ﹤0.01% | 1866 |
|
|
2022
Q1 | $2.05M | Buy |
84,966
+65,224
| +330% | +$1.57M | ﹤0.01% | 1494 |
|
|
2021
Q4 | $646 | Buy |
19,742
+352
| +2% | +$12 | ﹤0.01% | 2096 |
|
|
2021
Q3 | $866K | Buy |
19,390
+308
| +2% | +$13.8K | ﹤0.01% | 1931 |
|
|
2021
Q2 | $722K | Buy |
19,082
+12,964
| +212% | +$491K | ﹤0.01% | 2182 |
|
|
2021
Q1 | $226K | Sell |
6,118
-62
| -1% | -$2.29K | ﹤0.01% | 2819 |
|
|
2020
Q4 | $205K | Buy |
+6,180
| New | +$205K | ﹤0.01% | 2758 |
|